               SEQUENCE LISTING

<110> INOVA BIOMEDICAL TECHNOLOGY S.R.L.

<120> METHOD FOR DETERMINING THE PRESENCE OF A TARGET MICROORGANISM IN A BIOLOGICAL SAMPLE

<130> 569-20

<160> 6

<170> BiSSAP 1.3.6

<210> 1
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> exposed protein

<400> 1
Gln Arg Lys Leu Ala Ala Lys Leu Thr 
1               5                   

<210> 2
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> exposed protein

<400> 2
Arg Val Arg Ser Ala Pro Ser Ser Ser 
1               5                   

<210> 3
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> exposed protein

<400> 3
Arg Lys Ile Leu Arg Ala Gly Pro Leu 
1               5                   

<210> 4
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> exposed protein

<400> 4
Ser Trp Ser Cys Thr Arg Tyr Ala Ala 
1               5                   

<210> 5
<211> 17
<212> DNA
<213> Artificial Sequence


<220> 
<223> reverse primer

<400> 5
gttttcccag tcacgac                                                   17


<210> 6
<211> 23
<212> DNA
<213> Artificial Sequence


<220> 
<223> forward primer

<400> 6
gctaccctcg ttccgatgct gtc                                            23


